Dr. Reddy's Laboratories Limited RDY
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 853.92M | 821.51M | 979.63M | 1.01B | 998.56M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 853.92M | 821.51M | 979.63M | 1.01B | 998.56M |
| Cost of Revenue | 456.72M | 453.27M | 454.21M | 457.15M | 430.32M |
| Gross Profit | 397.20M | 368.24M | 525.42M | 551.41M | 568.24M |
| SG&A Expenses | 304.94M | 303.43M | 302.17M | 302.81M | 299.70M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -5.05M | -7.57M | -6.63M | -8.48M | -9.10M |
| Total Operating Expenses | 817.62M | 808.84M | 818.77M | 822.52M | 793.89M |
| Operating Income | 36.30M | 12.67M | 160.86M | 186.04M | 204.67M |
| Income Before Tax | 58.47M | 21.76M | 173.20M | 210.19M | 222.58M |
| Income Tax Expenses | 12.46M | -2.34M | 39.66M | 46.74M | 57.86M |
| Earnings from Continuing Operations | 46.01M | 24.10M | 133.54M | 163.44M | 164.72M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 920.50K | -43.70K | 2.27M | 1.19M | 958.20K |
| Net Income | 46.93M | 24.06M | 135.81M | 164.63M | 165.68M |
| EBIT | 36.30M | 12.67M | 160.86M | 186.04M | 204.67M |
| EBITDA | 93.14M | 55.01M | 219.38M | 243.90M | 260.36M |
| EPS Basic | 0.06 | 0.03 | 0.16 | 0.20 | 0.20 |
| Normalized Basic EPS | 0.03 | 0.01 | 0.13 | 0.15 | 0.16 |
| EPS Diluted | 0.06 | 0.03 | 0.16 | 0.20 | 0.20 |
| Normalized Diluted EPS | 0.03 | 0.01 | 0.13 | 0.15 | 0.16 |
| Average Basic Shares Outstanding | 833.65M | 833.71M | 832.62M | 832.68M | 832.04M |
| Average Diluted Shares Outstanding | 833.65M | 833.71M | 833.20M | 833.16M | 833.02M |
| Dividend Per Share | -- | 0.09 | -- | -- | -- |
| Payout Ratio | -- | 0.00% | 0.00% | 46.33% | -- |